Personal profile

Education / Academic qualification

PhD, Aligarh Muslim University


  • tumor microenvironment
  • tumor biology

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 8 Similar Profiles
Nuclear Receptor Co-Repressor 1 Medicine & Life Sciences
Morphine Medicine & Life Sciences
Nuclear Receptor Subfamily 2, Group C, Member 1 Medicine & Life Sciences
Histone Deacetylases Medicine & Life Sciences
Ligands Medicine & Life Sciences
Platelet-Derived Growth Factor beta Receptor Medicine & Life Sciences
Tretinoin Medicine & Life Sciences
mu Opioid Receptor Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2015 2018

Research Output 2000 2018

Preclinical Evidence for Combined Use of Aromatase Inhibitors and NSAIDs as Preventive Agents of Tobacco-Induced Lung Cancer

Stabile, L. P., Farooqui, M., Kanterewicz, B., Abberbock, S., Kurland, B. F., Diergaarde, B. & Siegfried, J. M. Mar 1 2018 In : Journal of Thoracic Oncology. 13, 3, p. e33-e34

Research output: Contribution to journalArticle

Aromatase Inhibitors
Non-Steroidal Anti-Inflammatory Agents
Lung Neoplasms
5 Citations

Interaction between the estrogen receptor and fibroblast growth factor receptor pathways in non-small cell lung cancer

Siegfried, J. M., Farooqui, M., Rothenberger, N. J., Dacic, S. & Stabile, L. P. Jan 1 2017 In : Oncotarget. 8, 15, p. 24063-24076 14 p.

Research output: Contribution to journalArticle

Fibroblast Growth Factor Receptors
Non-Small Cell Lung Carcinoma
Estrogen Receptors
Fibroblast Growth Factors
Fibroblast Growth Factor 2

Opioids and opioid receptors orchestrate wound repair

Wang, Y., Gupta, M., Poonawala, T., Farooqui, M., Li, Y., Peng, F., Rao, S., Ansonoff, M., Pintar, J. E. & Gupta, K. Jul 1 2017 In : Translational Research. 185, p. 13-23 11 p.

Research output: Contribution to journalArticle

mu Opioid Receptor
Opioid Receptors
Opioid Analgesics
Wounds and Injuries
6 Citations

Phase 1/2 study of rilotumumab (AMG 102), a hepatocyte growth factor inhibitor, and erlotinib in patients with advanced non–small cell lung cancer

Tarhini, A. A., Rafique, I., Floros, T., Tran, P., Gooding, W. E., Villaruz, L. C., Burns, T. F., Friedland, D. M., Petro, D. P., Farooqui, M., Gomez-Garcia, J., Gaither-Davis, A., Dacic, S., Argiris, A., Socinski, M. A., Stabile, L. P. & Siegfried, J. M. Aug 1 2017 In : Cancer. 123, 15, p. 2936-2944 9 p.

Research output: Contribution to journalArticle

Growth Inhibitors
Hepatocyte Growth Factor
Non-Small Cell Lung Carcinoma
Epidermal Growth Factor Receptor
Confidence Intervals
7 Citations

Epiregulin contributes to breast tumorigenesis through regulating matrix metalloproteinase 1 and promoting cell survival

Farooqui, M., Bohrer, L. R., Brady, N. J., Chuntova, P., Kemp, S. E., Wardwell, C. T., Nelson, A. C. & Schwertfeger, K. L. Jul 29 2015 In : Molecular Cancer. 14, 1, 138

Research output: Contribution to journalArticle

Matrix Metalloproteinase 1
Cell Survival
Carcinoma, Intraductal, Noninfiltrating